Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 13, 2023

BUY
$96.41 - $126.61 $43,577 - $57,227
452 Added 27.07%
2,122 $219,000
Q2 2023

Jul 14, 2023

BUY
$118.5 - $160.53 $17,182 - $23,276
145 Added 9.51%
1,670 $202,000
Q1 2023

Apr 19, 2023

SELL
$135.66 - $197.02 $96,725 - $140,475
-713 Reduced 31.86%
1,525 $234,000
Q4 2022

Jan 18, 2023

SELL
$118.38 - $210.04 $126,548 - $224,532
-1,069 Reduced 32.33%
2,238 $0
Q3 2022

Oct 18, 2022

BUY
$118.07 - $194.18 $390,457 - $642,153
3,307 New
3,307 $391,000
Q2 2022

Jul 15, 2022

SELL
$117.13 - $176.59 $158,125 - $238,396
-1,350 Closed
0 $0
Q1 2022

Apr 14, 2022

BUY
$126.46 - $235.05 $1,896 - $3,525
15 Added 1.12%
1,350 $233,000
Q4 2021

Jan 18, 2022

SELL
$225.82 - $368.51 $13,775 - $22,479
-61 Reduced 4.37%
1,335 $339,000
Q3 2021

Oct 14, 2021

BUY
$221.9 - $484.47 $309,772 - $676,320
1,396 New
1,396 $537,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ritholtz Wealth Management Portfolio

Follow Ritholtz Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Ritholtz Wealth Management with notifications on news.